Macquarie Group’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-283
| Closed | -$13.7K | – | 1748 |
|
|
2025
Q1 | $13.7K | Buy |
+283
| New | +$13.7K | ﹤0.01% | 1625 |
|
|
2022
Q4 | – | Hold |
0
| – | -$3K | – | 2221 |
|
|
2022
Q3 | – | Sell |
-307
| Closed | -$2K | – | 2481 |
|
|
2022
Q2 | $2K | Hold |
307
| – | – | ﹤0.01% | 2558 |
|
|
2022
Q1 | $7 | Hold |
307
| – | – | ﹤0.01% | 2551 |
|
|
2021
Q4 | $10K | Hold |
307
| – | – | ﹤0.01% | 2513 |
|
|
2021
Q3 | $5K | Hold |
307
| – | – | ﹤0.01% | 2596 |
|
|
2021
Q2 | $14K | Sell |
307
-1,432
| -82% | -$65.3K | ﹤0.01% | 2433 |
|
|
2021
Q1 | $45K | Buy |
+1,739
| New | +$45K | ﹤0.01% | 2101 |
|
|
2019
Q1 | – | Sell |
-2,282
| Closed | -$15K | – | 1955 |
|
|
2018
Q4 | $15K | Sell |
2,282
-4,144
| -64% | -$27.2K | ﹤0.01% | 1852 |
|
|
2018
Q3 | $66K | Sell |
6,426
-6,700
| -51% | -$68.8K | ﹤0.01% | 1674 |
|
|
2018
Q2 | $88K | Buy |
13,126
+7,700
| +142% | +$51.6K | ﹤0.01% | 1869 |
|
|
2018
Q1 | $47K | Buy |
+5,426
| New | +$47K | ﹤0.01% | 1995 |
|